Diprenorphine

DB01548

small molecule illicit vet_approved

Deskripsi

A narcotic antagonist similar in action to naloxone. It is used to remobilize animals after etorphine neuroleptanalgesia and is considered a specific antagonist to etorphine. PubChem

Struktur Molekul 2D

Berat 425.569
Wujud solid

Peta Jejaring Molekuler
Legenda: ObatTargetGenEnzim(Panah → menunjukkan arah efek / relasi)TransporterCarrier

Profil Farmakokinetik

Waktu Paruh (Half-Life) -
Volume Distribusi -
Klirens (Clearance) -

Absorpsi

Data absorpsi tidak tersedia.

Metabolisme

Data metabolisme tidak tersedia.

Rute Eliminasi

Data eliminasi belum tersedia.

Interaksi Obat

54 Data
Methylnaltrexone Diprenorphine may increase the opioid antagonism activities of Methylnaltrexone.
Naloxegol Diprenorphine may increase the opioid antagonism activities of Naloxegol.
Tramadol The therapeutic efficacy of Tramadol can be decreased when used in combination with Diprenorphine.
Morphine The therapeutic efficacy of Morphine can be decreased when used in combination with Diprenorphine.
Codeine The therapeutic efficacy of Codeine can be decreased when used in combination with Diprenorphine.
Hydromorphone The therapeutic efficacy of Hydromorphone can be decreased when used in combination with Diprenorphine.
Methadone The therapeutic efficacy of Methadone can be decreased when used in combination with Diprenorphine.
Meperidine The therapeutic efficacy of Meperidine can be decreased when used in combination with Diprenorphine.
Oxycodone The therapeutic efficacy of Oxycodone can be decreased when used in combination with Diprenorphine.
Butorphanol The therapeutic efficacy of Butorphanol can be decreased when used in combination with Diprenorphine.
Dextropropoxyphene The therapeutic efficacy of Dextropropoxyphene can be decreased when used in combination with Diprenorphine.
Pentazocine The therapeutic efficacy of Pentazocine can be decreased when used in combination with Diprenorphine.
Naltrexone The therapeutic efficacy of Naltrexone can be decreased when used in combination with Diprenorphine.
Sufentanil The therapeutic efficacy of Sufentanil can be decreased when used in combination with Diprenorphine.
Alfentanil The therapeutic efficacy of Alfentanil can be decreased when used in combination with Diprenorphine.
Fentanyl The therapeutic efficacy of Fentanyl can be decreased when used in combination with Diprenorphine.
Nalbuphine The therapeutic efficacy of Nalbuphine can be decreased when used in combination with Diprenorphine.
Levorphanol The therapeutic efficacy of Levorphanol can be decreased when used in combination with Diprenorphine.
Remifentanil The therapeutic efficacy of Remifentanil can be decreased when used in combination with Diprenorphine.
Buprenorphine The therapeutic efficacy of Buprenorphine can be decreased when used in combination with Diprenorphine.
Hydrocodone The therapeutic efficacy of Hydrocodone can be decreased when used in combination with Diprenorphine.
Diphenoxylate The therapeutic efficacy of Diphenoxylate can be decreased when used in combination with Diprenorphine.
Oxymorphone The therapeutic efficacy of Oxymorphone can be decreased when used in combination with Diprenorphine.
Dezocine The therapeutic efficacy of Dezocine can be decreased when used in combination with Diprenorphine.
Levacetylmethadol The therapeutic efficacy of Levacetylmethadol can be decreased when used in combination with Diprenorphine.
Methadyl acetate The therapeutic efficacy of Methadyl acetate can be decreased when used in combination with Diprenorphine.
Dihydroetorphine The therapeutic efficacy of Dihydroetorphine can be decreased when used in combination with Diprenorphine.
Diamorphine The therapeutic efficacy of Diamorphine can be decreased when used in combination with Diprenorphine.
Bezitramide The therapeutic efficacy of Bezitramide can be decreased when used in combination with Diprenorphine.
Ethylmorphine The therapeutic efficacy of Ethylmorphine can be decreased when used in combination with Diprenorphine.
Etorphine The therapeutic efficacy of Etorphine can be decreased when used in combination with Diprenorphine.
Dextromoramide The therapeutic efficacy of Dextromoramide can be decreased when used in combination with Diprenorphine.
Desomorphine The therapeutic efficacy of Desomorphine can be decreased when used in combination with Diprenorphine.
Carfentanil The therapeutic efficacy of Carfentanil can be decreased when used in combination with Diprenorphine.
Dihydrocodeine The therapeutic efficacy of Dihydrocodeine can be decreased when used in combination with Diprenorphine.
Alphacetylmethadol The therapeutic efficacy of Alphacetylmethadol can be decreased when used in combination with Diprenorphine.
Dihydromorphine The therapeutic efficacy of Dihydromorphine can be decreased when used in combination with Diprenorphine.
Tapentadol The therapeutic efficacy of Tapentadol can be decreased when used in combination with Diprenorphine.
Ketobemidone The therapeutic efficacy of Ketobemidone can be decreased when used in combination with Diprenorphine.
DPDPE The therapeutic efficacy of DPDPE can be decreased when used in combination with Diprenorphine.
Lofentanil The therapeutic efficacy of Lofentanil can be decreased when used in combination with Diprenorphine.
Eluxadoline The therapeutic efficacy of Eluxadoline can be decreased when used in combination with Diprenorphine.
Opium The therapeutic efficacy of Opium can be decreased when used in combination with Diprenorphine.
Normethadone The therapeutic efficacy of Normethadone can be decreased when used in combination with Diprenorphine.
Piritramide The therapeutic efficacy of Piritramide can be decreased when used in combination with Diprenorphine.
Alphaprodine The therapeutic efficacy of Alphaprodine can be decreased when used in combination with Diprenorphine.
Nicomorphine The therapeutic efficacy of Nicomorphine can be decreased when used in combination with Diprenorphine.
Meptazinol The therapeutic efficacy of Meptazinol can be decreased when used in combination with Diprenorphine.
Phenoperidine The therapeutic efficacy of Phenoperidine can be decreased when used in combination with Diprenorphine.
Phenazocine The therapeutic efficacy of Phenazocine can be decreased when used in combination with Diprenorphine.
Tilidine The therapeutic efficacy of Tilidine can be decreased when used in combination with Diprenorphine.
Carfentanil, C-11 The therapeutic efficacy of Carfentanil, C-11 can be decreased when used in combination with Diprenorphine.
Benzhydrocodone The therapeutic efficacy of Benzhydrocodone can be decreased when used in combination with Diprenorphine.
Oliceridine The therapeutic efficacy of Oliceridine can be decreased when used in combination with Diprenorphine.

Target Protein

Mu-type opioid receptor OPRM1
Delta-type opioid receptor OPRD1
Kappa-type opioid receptor OPRK1
E3 ubiquitin-protein ligase TRIM13 TRIM13

Referensi & Sumber

Belum ada data referensi/link/attachment untuk obat ini pada database. Jalankan import DrugBank untuk mengisi field referensi.

Contoh Produk & Brand

Produk: 0 • International brands: 2
International Brands
  • M5050
  • Revivon

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.
© 2025 Digital Pharmacy Research - Universitas Esa Unggul